Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,689
Views
0
CrossRef citations to date
0
Altmetric
Musculoskeletal
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
Hana Al-Abdulkarima National Guard Health Affairs, Riyadh, Saudi Arabia;b King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia;c Doctoral School of Applied Informatics and Applied Mathematics, Óbuda University, Budapest, HungaryView further author information
, Yuvraj Sharmad IQVIA, London, UKView further author information
, Suzan M. Attare Rheumatology & Internal Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaView further author information
, Waleed Husainf Heraa Hospital, Makkah, Saudi ArabiaView further author information
, Ibrahim Al-Homoodg Internal Medicine Department, King Fahad Medical City, Riyadh, Saudi ArabiaView further author information
, Bedor Al Omarih Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaView further author information
, Omneya Mohamedi Real-World Evidence (RWE), IQVIA AG, Dubai, United Arab EmiratesView further author information
, Mai Alsaqa’abyj Real-World Evidence (RWE), IQVIA Solutions, Riyadh, Saudi ArabiaCorrespondence[email protected]
https://orcid.org/0000-0001-8369-5044View further author information
, https://orcid.org/0000-0001-8369-5044View further author information
Ahmed M. Jaheenk Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information
, Ali Anwark Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information
, Tharwat M. Hamadk Branch of AbbVie Biopharmaceuticals GmbH, Scientific Office, Riyadh, Saudi ArabiaView further author information
& Zeyad Alzahranil Department of Surgery, King Abdulaziz Medical City, Jeddah, Saudi ArabiaView further author information
show all
Pages 134-144
|
Received 18 Sep 2023, Accepted 21 Dec 2023, Published online: 01 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.